Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 2113-2117, April 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagata, T.
Right arrow Articles by Tobe, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagata, T.
Right arrow Articles by Tobe, T.

Deletion of 17p and Amplification of the int-2 Gene in Esophageal Carcinomas1

Takashi Wagata, Kanji Ishizaki2, Masayuki Imamura, Yutaka Shimada, Mituo Ikenaga and Takayoshi Tobe

Radiation Biology Center (T. W., K. I., M. Ik.) and First Department of Surgery, Faculty of Medicine (T. W., M. Im., Y. S., T. T.), Kyoto University, Yoshida-Konoecho, Sakyo-ku, Kyoto 606, Japan

We have analyzed allelic deletion at 23 loci on 18 different chromosomes in 35 esophageal squamous cell carcinoma tissues by using restriction fragment length polymorphism markers. Loss of heterozygosity was detected on chromosomes 2, 3, 6, 7, 11–14, 16–18, 21, and 22, while no loss was detected on chromosomes 1, 4, and 8–10. Only the loss of chromosome 17p was detected with high frequency (45%), and losses on other chromosomes had frequencies of <22%. These losses with low frequencies might be random losses caused by chromosomal rearrangement during the course of tumor development and progression. On the contrary, the loss of 17p might play an important role in the development of esophageal squamous cell carcinoma, such as inactivation of a tumor suppressor gene. Amplification of the int-2 gene was observed in 39% of the tumors. However, no significant relationship between int-2 amplification and the deletion of any chromosome was detected.

1 This study was supported in part by a grant from the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed.

Received 10/ 4/90. Accepted 2/ 1/91.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S Salahshor and J R Woodgett
The links between axin and carcinogenesis
J. Clin. Pathol., March 1, 2005; 58(3): 225 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Naidoo, A Ramburan, A Reddi, and R Chetty
Aberrations in the mismatch repair genes and the clinical impact on oesophageal squamous carcinomas from a high incidence area in South Africa
J. Clin. Pathol., March 1, 2005; 58(3): 281 - 284.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Harada, H. Tanaka, Y. Shimada, M. Shinoda, M. Imamura, and K. Ishizaki
Lymph Node Metastasis Is Associated with Allelic Loss on Chromosome 13q12-13 in Esophageal Squamous Cell Carcinoma1
Cancer Res., August 1, 1999; 59(15): 3724 - 3729.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.